ArticleTherapeutic advances in infectious disease

Donepezil-associated survival benefits among Alzheimer's disease patients are retained but not enhanced during COVID-19 infections.

Elizabeth A Edmiston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.